Honliv Healthcare Management Group Company Limited (HKG:9906)

HKG:9906 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	10.44	31.15	38.31	48.95	36.62	21.84
Depreciation & Amortization	73.37	73.37	59.72	54.76	33.71	28.51
Other Amortization	1.15	1.15	0.52	-	-	-
Loss (Gain) From Sale of Assets	-1.28	-1.28	0.02	0.02	0.06	0
Asset Writedown & Restructuring Costs	-	-	-	4.45	-	-
Provision & Write-off of Bad Debts	0.53	0.53	15.29	1.96	0.09	4.61
Other Operating Activities	49.56	5.53	8.74	-1.99	17.44	32.19
Change in Accounts Receivable	-32.64	-32.64	0.42	-14.82	-15.53	-6.68
Change in Inventory	-7.72	-7.72	-2.35	-2.36	-6.43	2.42
Change in Accounts Payable	-23.58	-23.58	22.74	-4.18	10.54	-19.46
Change in Other Net Operating Assets	36.82	36.82	-51.85	31.69	14.95	11.19
Operating Cash Flow	106.66	83.34	91.56	118.47	91.44	74.61
Operating Cash Flow Growth	27.97%	-8.97%	-22.72%	29.56%	22.56%	-13.29%

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Capital Expenditures	-37.58	-49.67	-89.25	-18.91	-51.02	-80.43
Sale of Property, Plant & Equipment	19.09	-	-	-	-	-
Sale (Purchase) of Intangibles	-1.67	-2.49	-0.3	-0.9	-0.34	-0.42
Other Investing Activities	0.77	0.77	0.79	0.65	0.9	0.79
Investing Cash Flow	-19.39	-51.38	-88.76	-19.16	-50.46	-80.06

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-Term Debt Issued	-	156.75	182.98	164	187	213
Total Debt Issued	124.15	156.75	182.98	164	187	213
Long-Term Debt Repaid	-	-161.47	-148.53	-211.19	-248.92	-239.45
Total Debt Repaid	-159.13	-161.47	-148.53	-211.19	-248.92	-239.45
Net Debt Issued (Repaid)	-34.98	-4.72	34.45	-47.19	-61.92	-26.45
Issuance of Common Stock	-	-	-	-	-	283.89
Repurchase of Common Stock	-17.44	-	-45.92	-61.31	-	-
Common Dividends Paid	-	-	-	-	-	-7.23
Other Financing Activities	-8.27	-8.58	-7.65	-9.35	-14.96	-35.06
Financing Cash Flow	-60.68	-13.3	-19.12	-117.85	-76.87	215.16

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Foreign Exchange Rate Adjustments	-0.01	0.08	0.84	10.17	-2.98	-11.83
Net Cash Flow	26.58	18.74	-15.48	-8.37	-38.87	197.88

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Free Cash Flow	69.07	33.67	2.31	99.56	40.42	-5.82
Free Cash Flow Growth	105.14%	1360.15%	-97.68%	146.30%	-	-
Free Cash Flow Margin	9.86%	4.38%	0.30%	13.68%	6.66%	-1.11%
Free Cash Flow Per Share	0.13	0.06	0.00	0.17	0.07	-0.01
Levered Free Cash Flow	43.35	-4.18	-12.78	86.61	15.23	-28.93
Unlevered Free Cash Flow	48.51	1.18	-8	92.46	23.94	-16.38

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash Interest Paid	8.27	8.58	7.65	9.35	14.96	20.97
Cash Income Tax Paid	4.47	13.45	10.14	14.54	12.5	7.95
Change in Working Capital	-27.12	-27.12	-31.04	10.32	3.53	-12.53

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 9, 2026

Data Sources Report a data error